Rotavirus vaccines: current global impact and future perspectives.

Area of Science:

• Immunology
• Public Health
• Pediatrics

Background:

• Rotavirus vaccines (Rotarix, RotaTeq) are integral to national immunization programs in 81 countries as of May 2016.
• Initial vaccine uptake varied, and vaccine effectiveness (VE) differs across socioeconomic settings.
• Rotavirus remains a significant cause of diarrheal disease globally, particularly in low- and middle-income countries.

Purpose of the Study:

• To evaluate the global impact and effectiveness of current rotavirus vaccines.
• To identify factors influencing vaccine effectiveness, such as nutrition and breastfeeding.
• To review emerging vaccines and alternative schedules for improved rotavirus prevention.

Main Methods:

• Analysis of data from countries with national immunization programs incorporating rotavirus vaccines.
• Review of published research on rotavirus vaccine effectiveness (VE) in diverse settings.
• Examination of studies investigating factors affecting VE, including nutritional status and infant feeding practices.

Main Results:

• Rotavirus vaccines have demonstrated swift and significant impact in reducing disease burden across high-, low-, and middle-income countries.
• Good VE was observed against both vaccine-type and nonvaccine-type rotavirus strains.
• Poor nutrition is linked to reduced VE, while breastfeeding at vaccination does not appear to affect the immune response.

Conclusions:

• Rotavirus vaccines are highly effective public health interventions with broad global impact.
• Nutritional status is a critical factor influencing rotavirus vaccine effectiveness.
• Ongoing research into new vaccines and schedules holds promise for further optimizing rotavirus disease prevention.